CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies：a Single-center, Open, Single-arm Clinical Study.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04008394
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:12.101002+00:00
Published At: 2019-08-07T00:00:00+00:00
Record Updated At: 2019-08-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Adult T-Cell Lymphoma/Leukaemia", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "NK/T-cell Lymphoma", "Peripheral T Cell Lymphoma", "Hodgkin Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-08-07"
protocolSection.identificationModule.nctId: "NCT04008394"
protocolSection.identificationModule.officialTitle: "Efficacy and Safety of Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies\uff1aa Single-center, Open, Single-arm Clinical Study."
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.